ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.85
-0.14%
US Tech 100
19,192.40
-0.37%
S&P 500
5,460.48
-0.41%
US Dollar vs CAD
1.36791
-0.15%
Bitcoin
60,155.99
-2.36%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Summit Therapeutics Inc (SMMT)

  7. Summit Therapeutics Inc (SMMT) News

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
06/27/20243:15PMBusiness WireSummit Therapeutics Appoints Jeff Huber, Transformational Google and GRAIL Executive, to its Board of DirectorsNASDAQ:SMMTSummit Therapeutics Inc
06/18/20244:14PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SMMTSummit Therapeutics Inc
06/17/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
06/13/20241:03PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SMMTSummit Therapeutics Inc
06/03/20245:18AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
06/03/20245:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
06/03/20244:30AMBusiness WireSummit Raises $200 Million; Also Expands License Territories for IvonescimabNASDAQ:SMMTSummit Therapeutics Inc
06/01/20247:00AMBusiness WireIvonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMANASDAQ:SMMTSummit Therapeutics Inc
05/31/20246:00PMBusiness Wire Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus ChemotherapyNASDAQ:SMMTSummit Therapeutics Inc
05/30/20245:00PMBusiness WireSummit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SMMTSummit Therapeutics Inc
05/30/20243:48PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
05/30/20241:29PMBusiness WireIvonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC in ChinaNASDAQ:SMMTSummit Therapeutics Inc
05/24/20247:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
05/13/20247:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
05/13/20246:48AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SMMTSummit Therapeutics Inc
05/01/20246:00AMBusiness WireSummit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024NASDAQ:SMMTSummit Therapeutics Inc
04/24/20243:30PMBusiness WireSummit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024NASDAQ:SMMTSummit Therapeutics Inc
04/11/20243:30PMBusiness WireSummit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of DirectorsNASDAQ:SMMTSummit Therapeutics Inc
04/10/20246:00AMBusiness WireSummit Therapeutics to Present at the Stifel 2024 Targeted Oncology ForumNASDAQ:SMMTSummit Therapeutics Inc
03/22/20246:00AMBusiness WirePromising Intracranial Anti-Tumor Activity and Safety Data for Ivonescimab in NSCLC Patients with Brain Metastases Featured at ELCC 2024NASDAQ:SMMTSummit Therapeutics Inc
03/14/20246:00AMBusiness WireIntracranial Anti-Tumor Activity and Safety of Ivonescimab in NSCLC Patients with Brain Metastases to be Featured at ELCC 2024NASDAQ:SMMTSummit Therapeutics Inc
03/05/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
03/05/20246:00AMBusiness WireSummit Therapeutics to Present at the Barclays 26th Annual Global Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
02/20/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
02/20/20246:55AMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SMMTSummit Therapeutics Inc
02/20/20246:32AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SMMTSummit Therapeutics Inc
02/20/20246:00AMBusiness WireSummit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2023NASDAQ:SMMTSummit Therapeutics Inc
02/15/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
02/14/20243:35PMEdgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:SMMTSummit Therapeutics Inc
02/14/20249:29AMBusiness WireSummit Therapeutics to Host Fourth Quarter & Full Year 2023 Financial Results & Operational Progress Call on February 20, 2024NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT

Your Recent History

USOTC
NNAX
New Momentum (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
EMGE
Emergent Health (PK)
USOTC
AFFU
Affluence (PK)
NASDAQ
PLUG
Plug Power
USOTC
ECSL
Ecare Solutions (PK)
USOTC
GDVM
Global Developments (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
GGSM
Gold and GemStone Mining (PK)
USOTC
RDGL
Vivos (QB)
USOTC
CRTG
Coretec (QB)
USOTC
SMCE
SMC Entertainment (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
HHSE
Hannover House (PK)
USOTC
UBQU
Ubiquitech Software (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved